Safety and Tolerability of Metformin and Naproxen for Cancer Prevention in Fanconi Anemia

Recruiting

Plain-English translation of NCT07901959 on ClinicalTrials.gov ↗ · Source last updated October 2026 · How we translate trials

Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.

Trial locations(2 sites)

United States

University of MInnesota, Minneapolis, Minnesota

The Rockefeller University, New York, New York

Key details

Phase

Safety & dosing

Sponsor

Rockefeller University

Collaborators

University of Minnesota, The Wellcome Sanger Institute

Enrollment target

~80 participants

Started

October 2026

Primary completion

October 2030

Age range

18 Years and older

Last updated on clinicaltrials.gov in October 2026.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Francis J May, MD

The Rockefeller University

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.

View full record on ClinicalTrials.gov